Vitamin D and methylarginines in chronic kidney disease (CKD).
BACKGROUND:Vitamin D associates with the plasma concentration of the endogenous inhibitor of the nitric oxide system asymmetric dimethyl arginine (ADMA) and cross-sectional studies in CKD patients treated with the vitamin D receptor activator paricalcitol show that plasma ADMA is substantially less...
Main Authors: | Claudia Torino, Patrizia Pizzini, Sebastiano Cutrupi, Rocco Tripepi, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5627906?pdf=render |
Similar Items
-
Chronic Kidney Disease (CKD) as a Systemic Disease: Whole Body Autoregulation and Inter-Organ Cross-Talk
by: Carmine Zoccali, et al.
Published: (2014-07-01) -
Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study
by: Panuccio Vincenzo, et al.
Published: (2012-10-01) -
Homoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patients.
by: Pietro Ravani, et al.
Published: (2013-01-01) -
INNATE IMMUNITY AND CKD PROGRESSION
by: Mallamaci F, et al.
Published: (2012-06-01) -
Sleep‐Disordered Breathing and 24‐Hour Ambulatory Blood Pressure Monitoring in Renal Transplant Patients: Longitudinal Study
by: Francesca Mallamaci, et al.
Published: (2020-07-01)